CBX Stock Overview
Cellular Goods PLC, together with its subsidiaries, manufactures and sells biosynthetic cannabinoids-based consumer products in the United Kingdom.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
My Notes
NewNotes are coming soon
Cellular Goods PLC Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.0057 |
52 Week High | UK£0.064 |
52 Week Low | UK£0.005 |
Beta | 0 |
1 Month Change | -20.69% |
3 Month Change | -65.15% |
1 Year Change | -90.17% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -96.97% |
Recent News & Updates
Shareholder Returns
CBX | GB Personal Products | GB Market | |
---|---|---|---|
7D | 4.5% | 1.2% | 1.1% |
1Y | -90.2% | 7.4% | -3.1% |
Return vs Industry: CBX underperformed the UK Personal Products industry which returned 7.4% over the past year.
Return vs Market: CBX underperformed the UK Market which returned -3.1% over the past year.
Price Volatility
CBX volatility | |
---|---|
CBX Average Weekly Movement | 13.8% |
Personal Products Industry Average Movement | 6.7% |
Market Average Movement | 5.1% |
10% most volatile stocks in GB Market | 11.2% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: CBX is more volatile than 90% of UK stocks over the past 3 months, typically moving +/- 14% a week.
Volatility Over Time: CBX's weekly volatility has decreased from 20% to 14% over the past year, but is still higher than 75% of UK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2018 | 5 | Darcy Taylor | https://www.cellulargoods.co |
Cellular Goods PLC, together with its subsidiaries, manufactures and sells biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online.
Cellular Goods PLC Fundamentals Summary
CBX fundamental statistics | |
---|---|
Market Cap | UK£2.79m |
Earnings (TTM) | -UK£5.99m |
Revenue (TTM) | UK£28.90k |
100.9x
P/S Ratio-0.5x
P/E RatioIs CBX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CBX income statement (TTM) | |
---|---|
Revenue | UK£28.90k |
Cost of Revenue | UK£10.79k |
Gross Profit | UK£18.12k |
Other Expenses | UK£6.01m |
Earnings | -UK£5.99m |
Last Reported Earnings
Aug 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.012 |
Gross Margin | 62.68% |
Net Profit Margin | -20,723.63% |
Debt/Equity Ratio | 0% |
How did CBX perform over the long term?
See historical performance and comparison